The surge in popularity of GLP-1 receptor agonists like Ozempic has raised concerns over significant long-term health risks. Users may experience severe muscle and bone loss, increased risks of depression, and negative alterations in emotional well-being. Discontinuing the drug can lead to regaining weight, particularly fat, at a worse ratio to muscle, while gastrointestinal side effects could escalate to serious conditions. Since 2018, thousands of adverse events related to these drugs have been reported, indicating potential dangers associated with their use.
Ozempic and other GLP-1 drugs may lead to severe loss of essential lean muscle and bone mass, contributing to physical weakness and a shorter lifespan.
The long-term psychological effects of Ozempic use include diminished emotional responses and an increased risk for depression and suicidal ideation due to brain chemistry alterations.
Collection
[
|
...
]